Multicenter , double-blind , placebo-controlled clinical trial ( Renal Optimization Strategies Evaluation [ ROSE ] ) of 360 hospitalized patients with acute heart failure and renal dysfunction ( estimated glomerular filtration rate of 15-60 mL/min/1 .73 m2 ) , randomized within 24 hours of admission .